Skip to main content

Table 3 Kidney Cystadenoma Subtypes

From: Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models

Lesion Subtype

Percentage Filled

Cystic

0%

Pre-papillary

0%< x < 25%

Papillary

25% ≤ x < 100%

Solid

100%